Barrow, Hanley, Mewhinney & Strauss’s LivaNova LIVN Stock Holding History
Bought
Maintained
Sold
Other funds holding LIVN
HRCM
Barrow, Hanley, Mewhinney & Strauss's LIVN Position: Q2 2026 in Review
Barrow, Hanley, Mewhinney & Strauss opened a new position in LivaNova (LIVN) in Q2 2026: 87 shares worth $7.15K. The stake represents ﹤0.01% of the portfolio and ranks #266 among its holdings. This is a return to the name: Barrow, Hanley, Mewhinney & Strauss previously reported a position in LIVN as recently as Q2 2025.
Barrow, Hanley, Mewhinney & Strauss first reported a position in LIVN in Q2 2020 and has held it in 22 quarters since. The position peaked at $187M in Q2 2021. 303 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss held 87 shares of LivaNova worth $7.15K as of Q2 2026.
- LivaNova was a new Barrow, Hanley, Mewhinney & Strauss position in Q2 2026.
- LivaNova made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #266 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in LivaNova in Q2 2020 and has held it in 22 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's LivaNova position peaked at $187M in Q2 2021.
- 303 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.